SCHEMBL13459601

SCHEMBL13459601

CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(-c4cccc5c(C(N)=O)nccc45)cc3)cc2C(F)(F)F)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 5/20 0.64
▸ KDR P35968 3/20 0.62
▸ MKNK2 Q9HBH9 5/20 0.53
▸ RIPK1 Q13546 3/20 0.53
▸ MKNK1 Q9BUB5 4/20 0.52
▸ CDK8 P49336 4/20 0.52
▸ SRC P12931 3/20 0.52
▸ ABL1 P00519 3/20 0.52
▸ CSF1R P07333 2/20 0.52
▸ PDGFRB P09619 2/20 0.52
▸ CDK2 P24941 2/20 0.52
▸ FLT3 P36888 2/20 0.52
▸ RAF1 P04049 2/20 0.52
▸ MAP3K7 O43318 2/20 0.52
▸ MAP4K2 Q12851 2/20 0.52
▸ MAPK14 Q16539 2/20 0.52
▸ BCR P11274 2/20 0.52
▸ FGFR4 P22455 2/20 0.52
▸ STK25 O00506 1/20 0.52
▸ CIT O14578 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13459938 0.91 RET (0.66) RETKDRMKNK2RIPK1MKNK1
SCHEMBL13459593 0.87 RET (0.64) RETKDRMKNK2RIPK1MKNK1
SCHEMBL13459818 0.84 RET (0.64) RETKDRMKNK2RIPK1MKNK1
SCHEMBL13459587 0.82 RET (0.55) RETKDRMKNK2RIPK1MKNK1
SCHEMBL13459841 0.81 RET (0.58) RETKDRMKNK2RIPK1MKNK1
SCHEMBL13459579 0.80 RIPK1 (0.79) KDRRIPK1PDGFRBRAF1
SCHEMBL13459820 0.77 RET (0.55) RETKDRMKNK2RIPK1MKNK1
SCHEMBL2821099 0.77 SRC (0.61) RETKDRCDK8SRCABL1
SCHEMBL27927274 0.77 ABL1 (0.60) RETKDRCDK8SRCABL1
SCHEMBL16380144 0.75 RET (0.63) RETKDRMKNK2RIPK1MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010032986-A2 NOVEL 5-(4-AMINOPHENYL)-ISOQUINOLINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PROPHYLAXIS AND TREATMENT OF MEDICAL CONDITION INDUCED BY RAF KINASE HYPERACTIVITY 주식회사 이큐스팜 (KR) 2010-03-25 — — WO disclosed
Send feedback